查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1405848

细胞膜穿透胜胜肽市场规模、份额、趋势分析报告：按类型、应用、最终用途、地区和细分市场预测，2024-2030

Cell Penetrating Peptide Market Size, Share & Trends Analysis Report By Type, By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10个工作天内

价格

细胞膜穿透胜胜肽市场成长与趋势：

根据Grand View Research, Inc.最新报告，预计到2030年，全球细胞膜穿透胜胜肽市场规模将达到28.5亿美元，2024年至2030年复合年增长率为10.08%。

对标靶给药方法的需求不断增长是推动成长的主要因素。化学修饰策略和胜肽合成技术的技术进步，以及引入精确治疗剂的研发活动的活性化，正在增加对细胞膜穿透胜胜肽的市场需求。

此外，基于CPP技术的新药核准正在增加，预计将在调查期间为主要参与者提供利润丰厚的机会。例如，2022年9月，Revance Therapeutics, Inc.的DAXXIFY获得美国食品药物管理局核准，该药物基于细胞穿透技术开发，用于暂时改善重度至中度鬓角。这项核准预计将促进市场成长。

胜肽生产过程的进步预计将推动市场的发展。製造商和供应商正致力于开发合成胜胜肽的新方法，例如细胞膜穿透胜胜肽。精製製程的改进和自动化以及减少废弃物的产生进一步增加了各种应用对 CPP 的需求。例如，2022年3月，Creative Peptides宣布推出创新胜胜肽药物研发服务，以加速胜肽疗法的开发，包括CPP疗法。

开拓利用细胞膜穿透胜胜肽治疗多种疾病的新药的资金开发预计将为市场相关人员开闢新的途径。例如，2022年9月，凯克研究生院从天使症候群治疗基金会获得了为期两年的50万美元研究津贴，用于支持针对天使症候群的CPP的研究工作。诸如此类的措施正在支持细胞膜穿透胜胜肽领域的发展。

然而，虽然细胞膜穿透胜胜肽当然可以在撑体上手动合成，但这些是费力且耗时的。新系统的设备成本从 30,000 美元到超过 200,000 美元不等，具体取决于合成规模和软体。因此，製造设备的高成本可能会阻碍小型公司和新兴经济体对细胞膜穿透胜胜肽的开发。同时，持续的技术进步可能会在预测期内推动CPP的应用。

细胞膜穿透胜胜肽市场报告亮点：

  • 按类型划分，合成 CPP 细分市场由于其在提供药物、显像剂和核酸等治疗分子方面的独特特性，将在 2023 年占据市场主导地位。
  • 从应用来看，药物递送领域由于毒性低且向目标细胞递送效率高，将在2023年占据最大的市场份额。
  • 按最终用途划分，製药和生物技术公司将在 2023 年引领市场。这是由于製药和生物技术公司在研发活动以及新诊断和治疗药物的生产中越来越多地使用胜肽。
  • 由于细胞膜穿透胜胜肽研究资金的增加、有利的政府政策、技术进步以及该地区主要营运商的存在，北美已经建立了强大的区域地位和最高的市场占有率。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章市场变数、趋势和范围

  • 市场区隔和范围
  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
  • 市场驱动因素
    • 胜肽合成技术的进展
    • 靶向药物传输的需求不断增长
    • 存在强大的管道
  • 市场抑制因素分析
    • 胜肽复杂度增加
    • 製造设备成本高
  • 营商环境分析
    • SWOT 分析；按因素（政治/法律、经济/技术）
    • 波特五力分析
    • COVID-19感染疾病的影响分析

第 4 章业务分析的类型

  • 细胞膜穿透胜胜肽市场：类型变异分析
  • 源自蛋白质的 CPP
  • 合成CPP
  • 嵌合体CPP

第 5 章应用程式的商业分析

  • 细胞膜穿透胜胜肽市场：应用变异分析
  • 药物输送
  • 基因转移
  • 诊断
  • 分子影像
  • 其他的

第 6 章最终用途业务分析

  • 细胞膜穿透胜胜肽市场：最终用途变异分析
  • 製药和生物技术公司
  • 合约研究组织（CRO）
  • 医院和诊所
  • 其他的

第七章 区域业务分析

  • 2023年及2030年细胞膜穿透胜胜肽依地区市场占有率
  • 北美洲
    • 2018-2030年北美细胞膜穿透胜胜肽市场
    • 美国
    • 加拿大
  • 欧洲
    • 2018-2030年欧洲细胞膜穿透胜胜肽市场
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 2018-2030年亚太细胞穿膜胜胜肽市场
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 拉丁美洲细胞膜穿透胜胜肽市场，2018-2030
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • MEA细胞膜穿透胜胜肽市场，2018-2030年
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章竞争形势

  • 参与企业概况
  • 财务绩效
  • 参与企业
    • 市场领导者
    • 2023年细胞膜穿透胜胜肽市场占有率分析
    • 公司简介
    • 策略规划
Product Code: GVR-4-68040-167-1

Cell Penetrating Peptide Market Growth & Trends:

The global cell penetrating peptide market size is expected to reach USD 2.85 billion by 2030, expandingat a CAGR of 10.08% from 2024 to 2030, according to a new report by Grand View Research, Inc. Growing demand for targeted drug delivery methods is the primary factor propelling the growth. Technological advancements in chemical modification strategies & peptide synthesis techniques and increasing R&D activities to introduce precise therapeutics are increasing the demand for cell penetrating peptides in the market.

Moreover, rising approvals of novel drugs based on CPP technology is expected to offer lucrative opportunities for the key players during the study period. For instance, in September 2022, Revance Therapeutics, Inc. received U.S. Food and Drug Administration approval for DAXXIFY, which is developed based on cell-penetrating technology for temporary improvement of severe to moderate frown lines. This approval is projected to boost the market growth.

Advancements in the production processes of peptides are expected to drive the market. Manufacturers and suppliers are focused on developing new methods for synthesizing peptides, such as cell penetrating peptides. Improvement and automation of the purification process and lower waste generation are further increasing the demand for CPPs in different applications. For instance, in March 2022, Creative Peptides introduced innovative peptide drug discovery services to speed the development of peptide therapeutics, including CPPs therapies.

Growing funding for developing novel drugs to treat numerous diseases using cell penetrating peptides is anticipated to open new avenues for the market stakeholders. For instance, in September 2022, the Keck Graduate Institute received a research grant of USD 500,000 from the Foundation for Angelman Syndrome Therapeutics for two years to support research activities related to CPPs to targetAngelman Syndrome. Such initiatives are boosting the cell penetrating peptide sector growth.

However, cell penetrating peptides can certainly be synthesized on solid support using manual methods, and these can be tedious and time-intensive. The equipment for new systems can cost from USD 30,000 to USD 200,000 and above, depending on the synthesis scale capability & software. Hence, the high cost of manufacturing equipment may hamper the development of cell penetrating peptides by small players and emerging economies. On the other hand, continuous technological advancements are likely to boost the applications of CPPs during the forecast period.

Cell Penetrating Peptide Market Report Highlights:

  • Based on type, the synthetic CPPs segment dominated the market in 2023 owing to their intrinsic property of delivering therapeutic molecules such as drugs, imaging agents, and nucleic acids
  • Based on application, the drug delivery segment held the largest segment share of the market in 2023, attributable to their low toxicity and efficiency of drug delivery into target cells
  • Based on end-use, the pharmaceutical & biotechnology companies segment led the market in 2023. It can be attributed to the rising utilization of peptides in pharmaceutical and biotechnology companies for R&D activities and the production of novel diagnostics and therapeutics
  • North America has established a strong regional position with a highest market share owing to the increasing funding for cell penetrating peptide research, favorable government policies, technological advancements, and the presence of key operating players in the region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation
    • 1.1.1. Market Definitions
  • 1.2. Objectives
    • 1.2.1. Objective - 1
    • 1.2.2. Objective - 2
    • 1.2.3. Objective - 3
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
  • 1.8. List Of Secondary Sources
  • 1.9. List Of Abbreviations
  • 1.10. List Of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Type, Application, and End-use Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers
    • 3.4.1. Technological Advancements of Peptide Synthesis
    • 3.4.2. Growing Demand for Targeted Drug Delivery
    • 3.4.3. Presence of Strong Pipeline
  • 3.5. Market Restraint Analysis
    • 3.5.1. Increasing Complexity of Peptides
    • 3.5.2. High Cost of Manufacturing Equipment
  • 3.6. Business Environment Analysis
    • 3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
    • 3.6.2. Porter's Five Forces Analysis
    • 3.6.3. COVID-19 Impact Analysis

Chapter 4. Type Business Analysis

  • 4.1. Cell Penetrating Peptide market: Type Movement Analysis
  • 4.2. Protein Derived CPPs
    • 4.2.1. Protein Derived CPPs Market, 2018 - 2030 (USD Million)
  • 4.3. Synthetic CPPs
    • 4.3.1. Synthetic CPPs Market, 2018 - 2030 (USD Million)
  • 4.4. Chimeric CPPs
    • 4.4.1. Chimeric CPPs Market, 2018 - 2030 (USD Million)

Chapter 5. Application Business Analysis

  • 5.1. Cell Penetrating Peptide Market: Application Movement Analysis
  • 5.2. Drug Delivery
    • 5.2.1. Drug Delivery Market, 2018 - 2030 (USD Million)
  • 5.3. Gene Delivery
    • 5.3.1. Gene Delivery Market, 2018 - 2030 (USD Million)
  • 5.4. Diagnostics
    • 5.4.1. Diagnostics Market, 2018 - 2030 (USD Million)
  • 5.5. Molecular Imaging
    • 5.5.1. Molecular Imaging Market, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. End-use Business Analysis

  • 6.1. Cell Penetrating Peptide Market: End-use Movement Analysis
  • 6.2. Pharmaceutical and Biotechnology Company
    • 6.2.1. Pharmaceutical and Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • 6.3. Contract Research Organizations (CROs)
    • 6.3.1. Contract Research Organizations (CROs) Market, 2018 - 2030 (USD Million)
  • 6.4. Hospitals and Clinics
    • 6.4.1. Hospitals and Clinics Market, 2018 - 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Cell Penetrating Peptide Market Share By Region, 2023 & 2030
  • 7.2. North America
    • 7.2.1. North America Cell Penetrating Peptide market, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. Key Country Dynamics
      • 7.2.2.2. Target Disease Prevalence
      • 7.2.2.3. Competitive Scenario
      • 7.2.2.4. Regulatory Framework
      • 7.2.2.5. Reimbursement Scenario
      • 7.2.2.6. U.S. Cell Penetrating Peptide market, 2018 - 2030 (USD MILLION)
    • 7.2.3. Canada
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Target Disease Prevalence
      • 7.2.3.3. Competitive Scenario
      • 7.2.3.4. Regulatory Framework
      • 7.2.3.5. Reimbursement Scenario
      • 7.2.3.6. Canada Cell Penetrating Peptide market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Cell Penetrating Peptide market, 2018 - 2030 (USD Million)
    • 7.3.2. Germany
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Target Disease Prevalence
      • 7.3.2.3. Competitive Scenario
      • 7.3.2.4. Regulatory Framework
      • 7.3.2.5. Reimbursement Scenario
      • 7.3.2.6. Germany Cell Penetrating Peptide market, 2018 - 2030 (USD Million)
    • 7.3.3. UK
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Target Disease Prevalence
      • 7.3.3.3. Competitive Scenario
      • 7.3.3.4. Regulatory Framework
      • 7.3.3.5. Reimbursement Scenario
      • 7.3.3.6. UK Cell Penetrating Peptide market, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Target Disease Prevalence
      • 7.3.4.3. Competitive Scenario
      • 7.3.4.4. Regulatory Framework
      • 7.3.4.5. Reimbursement Scenario
      • 7.3.4.6. France Cell Penetrating Peptide market, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Target Disease Prevalence
      • 7.3.5.3. Competitive Scenario
      • 7.3.5.4. Regulatory Framework
      • 7.3.5.5. Reimbursement Scenario
      • 7.3.5.6. Italy Cell Penetrating Peptide market, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Target Disease Prevalence
      • 7.3.6.3. Competitive Scenario
      • 7.3.6.4. Regulatory Framework
      • 7.3.6.5. Reimbursement Scenario
      • 7.3.6.6. Spain Cell Penetrating Peptide market, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Target Disease Prevalence
      • 7.3.7.3. Competitive Scenario
      • 7.3.7.4. Regulatory Framework
      • 7.3.7.5. Reimbursement Scenario
      • 7.3.7.6. Denmark Cell Penetrating Peptide market, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Target Disease Prevalence
      • 7.3.8.3. Competitive Scenario
      • 7.3.8.4. Regulatory Framework
      • 7.3.8.5. Reimbursement Scenario
      • 7.3.8.6. Sweden Cell Penetrating Peptide market, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Target Disease Prevalence
      • 7.3.9.3. Competitive Scenario
      • 7.3.9.4. Regulatory Framework
      • 7.3.9.5. Reimbursement Scenario
      • 7.3.9.6. Norway Cell Penetrating Peptide market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Cell Penetrating Peptide market, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Target Disease Prevalence
      • 7.4.2.3. Competitive Scenario
      • 7.4.2.4. Regulatory Framework
      • 7.4.2.5. Reimbursement Scenario
      • 7.4.2.6. Japan Cell Penetrating Peptide market, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Target Disease Prevalence
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. Regulatory Framework
      • 7.4.3.5. Reimbursement Scenario
      • 7.4.3.6. China Cell Penetrating Peptide market, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Target Disease Prevalence
      • 7.4.4.3. Competitive Scenario
      • 7.4.4.4. Regulatory Framework
      • 7.4.4.5. Reimbursement Scenario
      • 7.4.4.6. India Cell Penetrating Peptide market, 2018 - 2030 (USD Million)
    • 7.4.5. South Korea
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Target Disease Prevalence
      • 7.4.5.3. Competitive Scenario
      • 7.4.5.4. Regulatory Framework
      • 7.4.5.5. Reimbursement Scenario
      • 7.4.5.6. South Korea Cell Penetrating Peptide market, 2018 - 2030 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Target Disease Prevalence
      • 7.4.6.3. Competitive Scenario
      • 7.4.6.4. Regulatory Framework
      • 7.4.6.5. Reimbursement Scenario
      • 7.4.6.6. Australia Cell Penetrating Peptide market, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Target Disease Prevalence
      • 7.4.7.3. Competitive Scenario
      • 7.4.7.4. Regulatory Framework
      • 7.4.7.5. Reimbursement Scenario
      • 7.4.7.6. Thailand Cell Penetrating Peptide market, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Cell Penetrating Peptide market, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Target Disease Prevalence
      • 7.5.2.3. Competitive Scenario
      • 7.5.2.4. Regulatory Framework
      • 7.5.2.5. Reimbursement Scenario
      • 7.5.2.6. Brazil Cell Penetrating Peptide market, 2018 - 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Target Disease Prevalence
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. Regulatory Framework
      • 7.5.3.5. Reimbursement Scenario
      • 7.5.3.6. Mexico Cell Penetrating Peptide market, 2018 - 2030 (USD Million)
    • 7.5.4. Argentina
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Target Disease Prevalence
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Regulatory Framework
      • 7.5.4.5. Reimbursement Scenario
      • 7.5.4.6. Argentina Cell Penetrating Peptide market, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. MEA Cell Penetrating Peptide market, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Target Disease Prevalence
      • 7.6.2.3. Competitive Scenario
      • 7.6.2.4. Regulatory Framework
      • 7.6.2.5. Reimbursement Scenario
      • 7.6.2.6. South Africa Cell Penetrating Peptide market, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Target Disease Prevalence
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. Regulatory Framework
      • 7.6.3.5. Reimbursement Scenario
      • 7.6.3.6. Saudi Arabia Cell Penetrating Peptide market, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Target Disease Prevalence
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. Regulatory Framework
      • 7.6.4.5. Reimbursement Scenario
      • 7.6.4.6. UAE Cell Penetrating Peptide market, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Target Disease Prevalence
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. Regulatory Framework
      • 7.6.5.5. Reimbursement Scenario
      • 7.6.5.6. Kuwait Cell Penetrating Peptide market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant's overview
  • 8.2. Financial performance
  • 8.3. Participant categorization
    • 8.3.1. Market Leaders
    • 8.3.2. Cell Penetrating Peptide market Share Analysis, 2023
    • 8.3.3. Company Profiles
      • 8.3.3.1. Pepscan
      • 8.3.3.1.1. Company Overview
      • 8.3.3.1.2. Financial Performance
      • 8.3.3.1.3. Product Benchmarking
      • 8.3.3.1.4. Strategic Initiatives
      • 8.3.3.2. Creative Peptides
      • 8.3.3.2.1. Company Overview
      • 8.3.3.2.2. Financial Performance
      • 8.3.3.2.3. Product Benchmarking
      • 8.3.3.2.4. Strategic Initiatives
      • 8.3.3.3. Cupidpeptides
      • 8.3.3.3.1. Company Overview
      • 8.3.3.3.2. Financial Performance
      • 8.3.3.3.3. Product Benchmarking
      • 8.3.3.3.4. Strategic Initiatives
      • 8.3.3.4. AltaBioscience Ltd
      • 8.3.3.4.1. Company Overview
      • 8.3.3.4.2. Financial Performance
      • 8.3.3.4.3. Product Benchmarking
      • 8.3.3.4.4. Strategic Initiatives
      • 8.3.3.5. AnaSpec
      • 8.3.3.5.1. Company Overview
      • 8.3.3.5.2. Financial Performance
      • 8.3.3.5.3. Product Benchmarking
      • 8.3.3.5.4. Strategic Initiatives
      • 8.3.3.6. Peptomyc
      • 8.3.3.6.1. Company Overview
      • 8.3.3.6.2. Financial Performance
      • 8.3.3.6.3. Product Benchmarking
      • 8.3.3.6.4. Strategic Initiatives
      • 8.3.3.7. BioAlps
      • 8.3.3.7.1. Company Overview
      • 8.3.3.7.2. Financial Performance
      • 8.3.3.7.3. Product Benchmarking
      • 8.3.3.7.4. Strategic Initiatives
      • 8.3.3.8. Sarepta Therapeutics, Inc.
      • 8.3.3.8.1. Company Overview
      • 8.3.3.8.2. Financial Performance
      • 8.3.3.8.3. Product Benchmarking
      • 8.3.3.8.4. Strategic Initiatives
      • 8.3.3.9. REVANCE THERAPEUTICS
      • 8.3.3.9.1. Company Overview
      • 8.3.3.9.2. Financial Performance
      • 8.3.3.9.3. Product Benchmarking
      • 8.3.3.9.4. Strategic Initiatives
      • 8.3.3.10. Polypeptide Group
      • 8.3.3.10.1. Company Overview
      • 8.3.3.10.2. Financial Performance
      • 8.3.3.10.3. Product Benchmarking
      • 8.3.3.10.4. Strategic Initiatives
      • 8.3.3.11. Bachem
      • 8.3.3.11.1. Company Overview
      • 8.3.3.11.2. Financial Performance
      • 8.3.3.11.3. Product Benchmarking
      • 8.3.3.11.4. Strategic Initiatives
    • 8.3.4. Strategy Mapping
      • 8.3.4.1. Expansion
      • 8.3.4.2. Acquisition
      • 8.3.4.3. Collaborations
      • 8.3.4.4. Disease Type/Drug Class Launch
      • 8.3.4.5. Partnerships
      • 8.3.4.6. Others

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 Global Cell Penetrating Peptide Market, by Region, 2018 - 2030 (USD Million)
  • Table 3 Global Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 4 Global Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 5 Global Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)
  • Table 6 North America Cell Penetrating Peptide Market, by Country, 2018 - 2030 (USD Million)
  • Table 7 North America Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 8 North America Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 9 North America Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)
  • Table 10 U.S. Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 11 U.S. Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 12 U.S. Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)
  • Table 13 Canada Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 14 Canada Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 15 Canada Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)
  • Table 16 Europe Cell Penetrating Peptide Market, by Country, 2018 - 2030 (USD Million)
  • Table 17 Europe Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 18 Europe Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 19 Europe Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)
  • Table 20 Germany Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 21 Germany Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 22 Germany Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)
  • Table 23 UK Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 24 UK Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 25 UK Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)
  • Table 26 France Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 27 France Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 28 France Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)
  • Table 29 Italy Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 30 Italy Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 31 Italy Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)
  • Table 32 Spain Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 33 Spain Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 34 Spain Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)
  • Table 35 Denmark Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 36 Denmark Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 37 Denmark Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)
  • Table 38 Sweden Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 39 Sweden Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 40 Sweden Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)
  • Table 41 Norway Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 42 Norway Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 43 Norway Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific Cell Penetrating Peptide Market, by Country, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)
  • Table 48 China Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 49 China Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 50 China Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)
  • Table 51 Japan Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 52 Japan Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 53 Japan Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)
  • Table 54 India Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 55 India Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 56 India Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)
  • Table 57 South Korea Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 58 South Korea Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 59 South Korea Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)
  • Table 60 Australia Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 61 Australia Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 62 Australia Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)
  • Table 63 Thailand Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 64 Thailand Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 65 Thailand Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)
  • Table 66 Latin America Cell Penetrating Peptide Market, by Country, 2018 - 2030 (USD Million)
  • Table 67 Latin America Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 68 Latin America Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 69 Latin America Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)
  • Table 70 Brazil Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 71 Brazil Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 72 Brazil Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)
  • Table 73 Mexico Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 74 Mexico Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 75 Mexico Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)
  • Table 76 Argentina Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 77 Argentina Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 78 Argentina Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 83 South Africa Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 84 South Africa Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 85 South Africa Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)
  • Table 89 UAE Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 90 UAE Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 91 UAE Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)
  • Table 92 Kuwait Cell Penetrating Peptide Market, by Type, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Cell Penetrating Peptide Market, by Application, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Cell Penetrating Peptide Market, By End-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Cell Penetrating Peptide Market Segmentation
  • Fig. 8 Market Snapshot, 2023
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 PESTEL Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 13 Porter's Five Forces Analysis
  • Fig. 14 Global Cell Penetrating Peptide Market: Disease Type Movement Analysis
  • Fig. 15 Global Cell Penetrating Peptide Market, by Protein-Derived CPPs, 2018 - 2030 (USD Million)
  • Fig. 16 Global Cell Penetrating Peptide Market, by Synthetic CPPs, 2018 - 2030 (USD Million)
  • Fig. 17 Global Cell Penetrating Peptide Market, by Chimeric CPPs, 2018 - 2030 (USD Million)
  • Fig. 18 Global Cell Penetrating Peptide Market: Application Movement Analysis
  • Fig. 19 Global Cell Penetrating Peptide Market, by Drug Delivery, 2018 - 2030 (USD Million)
  • Fig. 20 Global Cell Penetrating Peptide Market, by Gene Delivery 2018 - 2030 (USD Million)
  • Fig. 21 Global Cell Penetrating Peptide Market, by Diagnostics, 2018 - 2030 (USD Million)
  • Fig. 22 Global Cell Penetrating Peptide Market, by Molecular Imaging 2018 - 2030 (USD Million)
  • Fig. 23 Global Cell Penetrating Peptide Market, by Others, 2018 - 2030 (USD Million)
  • Fig. 24 Global Cell Penetrating Peptide Market: End-use Movement Analysis
  • Fig. 25 Global Cell Penetrating Peptide Market, by Pharmaceutical and Biotechnology Company 2018 - 2030 (USD Million)
  • Fig. 26 Global Cell Penetrating Peptide Market, by Contract Research Organization (CROs) 2018 - 2030 (USD Million)
  • Fig. 27 Global Cell Penetrating Peptide Market, by Hospital and Clinics, 2018 - 2030 (USD Million)
  • Fig. 28 Global Cell Penetrating Peptide Market, by Others, 2018 - 2030 (USD Million)
  • Fig. 29 Regional Marketplace: Key Takeaways
  • Fig. 30 Regional Outlook, 2023 & 2030
  • Fig. 31 Global Cell Penetrating Peptide Market: Region Movement Analysis
  • Fig. 32 North America Cell Penetrating Peptide Market, 2018 - 2030 (USD Million)
  • Fig. 33 U.S. Cell Penetrating Peptide Market, 2018 - 2030 (USD Million)
  • Fig. 34 Canada Cell Penetrating Peptide Market, 2018 - 2030 (USD Million)
  • Fig. 35 Europe Cell Penetrating Peptide Market, 2018 - 2030 (USD Million)
  • Fig. 36 Germany Cell Penetrating Peptide Market, 2018 - 2030 (USD Million)
  • Fig. 37 UK Cell Penetrating Peptide Market, 2018 - 2030 (USD Million)
  • Fig. 38 France Cell Penetrating Peptide Market, 2018 - 2030 (USD Million)
  • Fig. 39 Italy Cell Penetrating Peptide Market, 2018 - 2030 (USD Million)
  • Fig. 40 Spain Cell Penetrating Peptide Market, 2018 - 2030 (USD Million)
  • Fig. 41 Denmark Cell Penetrating Peptide Market, 2018 - 2030 (USD Million)
  • Fig. 42 Sweden Cell Penetrating Peptide Market, 2018 - 2030 (USD Million)
  • Fig. 43 Norway Cell Penetrating Peptide Market, 2018 - 2030 (USD Million)
  • Fig. 44 Asia Pacific Cell Penetrating Peptide Market, 2018 - 2030 (USD Million)
  • Fig. 45 Japan Cell Penetrating Peptide Market, 2018 - 2030 (USD Million)
  • Fig. 46 China Cell Penetrating Peptide Market, 2018 - 2030 (USD Million)
  • Fig. 47 India Cell Penetrating Peptide Market, 2018 - 2030 (USD Million)
  • Fig. 48 Australia Cell Penetrating Peptide Market, 2018 - 2030 (USD Million)
  • Fig. 49 South Korea Cell Penetrating Peptide Market, 2018 - 2030 (USD Million)
  • Fig. 50 Thailand Cell Penetrating Peptide Market, 2018 - 2030 (USD Million)
  • Fig. 51 Latin America Cell Penetrating Peptide Market, 2018 - 2030 (USD Million)
  • Fig. 52 Brazil Cell Penetrating Peptide Market, 2018 - 2030 (USD Million)
  • Fig. 53 Mexico Cell Penetrating Peptide Market, 2018 - 2030 (USD Million)
  • Fig. 54 Argentina Cell Penetrating Peptide Market, 2018 - 2030 (USD Million)
  • Fig. 55 Middle East and Africa Cell Penetrating Peptide Market, 2018 - 2030 (USD Million)
  • Fig. 56 South Africa Cell Penetrating Peptide Market, 2018 - 2030 (USD Million)
  • Fig. 57 Saudi Arabia Cell Penetrating Peptide Market, 2018 - 2030 (USD Million)
  • Fig. 58 UAE Cell Penetrating Peptide Market, 2018 - 2030 (USD Million)
  • Fig. 59 Kuwait Cell Penetrating Peptide Market, 2018 - 2030 (USD Million)